

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of skeletal muscle contraction (GO:0014819) | 9.83619577 |
| 2 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 9.38908961 |
| 3 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 8.43222799 |
| 4 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 8.38991086 |
| 5 | sarcomere organization (GO:0045214) | 8.13179153 |
| 6 | actin filament-based movement (GO:0030048) | 8.10735119 |
| 7 | positive regulation of myotube differentiation (GO:0010831) | 7.60506442 |
| 8 | striated muscle contraction (GO:0006941) | 7.30074417 |
| 9 | response to inactivity (GO:0014854) | 6.45218937 |
| 10 | myofibril assembly (GO:0030239) | 6.23419290 |
| 11 | actomyosin structure organization (GO:0031032) | 6.20511504 |
| 12 | glycerophospholipid catabolic process (GO:0046475) | 5.89780239 |
| 13 | positive regulation of myoblast differentiation (GO:0045663) | 5.83592868 |
| 14 | negative regulation of protein localization to cell surface (GO:2000009) | 5.75217345 |
| 15 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 5.57730070 |
| 16 | regulation of sequestering of triglyceride (GO:0010889) | 5.57072447 |
| 17 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 5.51561913 |
| 18 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.35641973 |
| 19 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 5.31938302 |
| 20 | histone H2A ubiquitination (GO:0033522) | 5.31437409 |
| 21 | skeletal muscle fiber development (GO:0048741) | 5.24347825 |
| 22 | myotube cell development (GO:0014904) | 5.12445542 |
| 23 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 5.11829725 |
| 24 | muscle cell fate commitment (GO:0042693) | 5.10475966 |
| 25 | plasma membrane repair (GO:0001778) | 5.08246044 |
| 26 | sodium-independent organic anion transport (GO:0043252) | 5.00158648 |
| 27 | regulation of sarcomere organization (GO:0060297) | 4.97910301 |
| 28 | type B pancreatic cell development (GO:0003323) | 4.97495461 |
| 29 | muscle organ development (GO:0007517) | 4.92756328 |
| 30 | regulation of cell communication by electrical coupling (GO:0010649) | 4.89370669 |
| 31 | muscle contraction (GO:0006936) | 4.85732985 |
| 32 | muscle structure development (GO:0061061) | 4.85564129 |
| 33 | regulation of skeletal muscle cell differentiation (GO:2001014) | 4.80448419 |
| 34 | chaperone-mediated protein transport (GO:0072321) | 4.76240016 |
| 35 | striated muscle atrophy (GO:0014891) | 4.71654006 |
| 36 | regulation of female gonad development (GO:2000194) | 4.68425913 |
| 37 | regulation of myoblast differentiation (GO:0045661) | 4.62772737 |
| 38 | skeletal muscle tissue development (GO:0007519) | 4.59392742 |
| 39 | male meiosis I (GO:0007141) | 4.54610445 |
| 40 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.47993209 |
| 41 | negative regulation of fatty acid transport (GO:2000192) | 4.47369935 |
| 42 | parturition (GO:0007567) | 4.43278569 |
| 43 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.40189504 |
| 44 | regulation of relaxation of muscle (GO:1901077) | 4.39586778 |
| 45 | retinol metabolic process (GO:0042572) | 4.39235335 |
| 46 | muscle system process (GO:0003012) | 4.33528334 |
| 47 | low-density lipoprotein particle clearance (GO:0034383) | 4.32076654 |
| 48 | negative regulation of norepinephrine secretion (GO:0010700) | 4.32044979 |
| 49 | white fat cell differentiation (GO:0050872) | 4.31927926 |
| 50 | muscle cell cellular homeostasis (GO:0046716) | 4.28530979 |
| 51 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.26495983 |
| 52 | mitochondrion distribution (GO:0048311) | 4.26244352 |
| 53 | skeletal muscle tissue regeneration (GO:0043403) | 4.22163670 |
| 54 | brown fat cell differentiation (GO:0050873) | 4.20124999 |
| 55 | positive regulation of glomerulus development (GO:0090193) | 4.18251318 |
| 56 | glycerolipid catabolic process (GO:0046503) | 4.17537529 |
| 57 | piRNA metabolic process (GO:0034587) | 4.16499191 |
| 58 | cardiac myofibril assembly (GO:0055003) | 4.14057844 |
| 59 | regulation of meiosis (GO:0040020) | 4.10522727 |
| 60 | meiosis I (GO:0007127) | 4.03524910 |
| 61 | response to parathyroid hormone (GO:0071107) | 4.03061235 |
| 62 | regulation of myotube differentiation (GO:0010830) | 4.02904210 |
| 63 | response to caffeine (GO:0031000) | 4.02594675 |
| 64 | muscle atrophy (GO:0014889) | 4.01577695 |
| 65 | response to muscle activity (GO:0014850) | 4.00224954 |
| 66 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.98124647 |
| 67 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 3.97057526 |
| 68 | RNA localization (GO:0006403) | 3.91649134 |
| 69 | regulation of pseudopodium assembly (GO:0031272) | 3.88737013 |
| 70 | keratan sulfate catabolic process (GO:0042340) | 3.87781144 |
| 71 | regulation of skeletal muscle fiber development (GO:0048742) | 3.82436309 |
| 72 | negative regulation of potassium ion transport (GO:0043267) | 3.82207921 |
| 73 | cardiac muscle contraction (GO:0060048) | 3.78194225 |
| 74 | positive regulation of skeletal muscle tissue development (GO:0048643) | 3.78053143 |
| 75 | regulation of meiosis I (GO:0060631) | 3.77984742 |
| 76 | regulation of striated muscle contraction (GO:0006942) | 3.74532512 |
| 77 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 3.73734955 |
| 78 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.72431235 |
| 79 | female gamete generation (GO:0007292) | 3.71430601 |
| 80 | ovulation from ovarian follicle (GO:0001542) | 3.71249230 |
| 81 | negative regulation of cell size (GO:0045792) | 3.69247952 |
| 82 | positive regulation of striated muscle cell differentiation (GO:0051155) | 3.66275678 |
| 83 | notochord development (GO:0030903) | 3.64968703 |
| 84 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.64819227 |
| 85 | triglyceride catabolic process (GO:0019433) | 3.63448904 |
| 86 | extracellular fibril organization (GO:0043206) | 3.62680660 |
| 87 | histone H2A monoubiquitination (GO:0035518) | 3.61545060 |
| 88 | negative regulation of hormone biosynthetic process (GO:0032353) | 3.60136226 |
| 89 | negative regulation of hormone metabolic process (GO:0032351) | 3.60136226 |
| 90 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 3.59704544 |
| 91 | meiotic cell cycle (GO:0051321) | 3.58626403 |
| 92 | biotin metabolic process (GO:0006768) | 3.57287170 |
| 93 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 3.57272313 |
| 94 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.54036969 |
| 95 | muscle fiber development (GO:0048747) | 3.52535711 |
| 96 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.51966388 |
| 97 | mitotic metaphase plate congression (GO:0007080) | 3.50731036 |
| 98 | male meiosis (GO:0007140) | 3.50079908 |
| 99 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 3.49584552 |
| 100 | triglyceride biosynthetic process (GO:0019432) | 3.42679134 |
| 101 | regulation of exit from mitosis (GO:0007096) | 3.42346226 |
| 102 | paraxial mesoderm development (GO:0048339) | 3.40015885 |
| 103 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 3.39683000 |
| 104 | musculoskeletal movement (GO:0050881) | 3.38870611 |
| 105 | multicellular organismal movement (GO:0050879) | 3.38870611 |
| 106 | acylglycerol biosynthetic process (GO:0046463) | 3.37831895 |
| 107 | neutral lipid biosynthetic process (GO:0046460) | 3.37831895 |
| 108 | tachykinin receptor signaling pathway (GO:0007217) | 3.37794747 |
| 109 | positive regulation of fatty acid oxidation (GO:0046321) | 3.37154347 |
| 110 | myotube differentiation (GO:0014902) | 3.36919265 |
| 111 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 3.35844529 |
| 112 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.35404693 |
| 113 | striated muscle tissue development (GO:0014706) | 3.34017475 |
| 114 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 3.32663637 |
| 115 | vitamin transmembrane transport (GO:0035461) | 3.31941538 |
| 116 | dopamine biosynthetic process (GO:0042416) | 3.31820874 |
| 117 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.30870225 |
| 118 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.29998122 |
| 119 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.29921966 |
| 120 | negative regulation of meiosis (GO:0045835) | 3.28471066 |
| 121 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.27956860 |
| 122 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.27956860 |
| 123 | regulation of muscle system process (GO:0090257) | 3.26823262 |
| 124 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 3.26591918 |
| 125 | negative regulation of muscle hypertrophy (GO:0014741) | 3.25781951 |
| 126 | striated muscle cell development (GO:0055002) | 3.23827238 |
| 127 | acylglycerol catabolic process (GO:0046464) | 3.22576595 |
| 128 | neutral lipid catabolic process (GO:0046461) | 3.22576595 |
| 129 | myoblast fusion (GO:0007520) | 3.21089572 |
| 130 | cardiac muscle cell development (GO:0055013) | 3.20774175 |
| 131 | glandular epithelial cell development (GO:0002068) | 3.19585159 |
| 132 | endocrine hormone secretion (GO:0060986) | 3.18682735 |
| 133 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.15348976 |
| 134 | regulation of membrane repolarization (GO:0060306) | 3.15020677 |
| 135 | regulation of muscle contraction (GO:0006937) | 3.14044874 |
| 136 | DNA damage induced protein phosphorylation (GO:0006975) | 3.12253163 |
| 137 | CDP-diacylglycerol metabolic process (GO:0046341) | 3.12159357 |
| 138 | myoblast migration (GO:0051451) | 3.10379111 |
| 139 | regulation of meiotic cell cycle (GO:0051445) | 3.10185952 |
| 140 | face morphogenesis (GO:0060325) | 3.09734695 |
| 141 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.09702131 |
| 142 | regulation of mitotic spindle organization (GO:0060236) | 3.09164247 |
| 143 | lipid storage (GO:0019915) | 3.09152360 |
| 144 | cardiac cell development (GO:0055006) | 3.09016654 |
| 145 | protein localization to endosome (GO:0036010) | 3.08549909 |
| 146 | negative regulation of heart rate (GO:0010459) | 3.07102737 |
| 147 | positive regulation of protein depolymerization (GO:1901881) | 3.04356742 |
| 148 | cell-cell junction maintenance (GO:0045217) | 3.02029399 |
| 149 | microtubule severing (GO:0051013) | 3.01840495 |
| 150 | primary alcohol metabolic process (GO:0034308) | 3.01614768 |
| 151 | negative regulation of TOR signaling (GO:0032007) | 3.01137927 |
| 152 | positive regulation of phosphatase activity (GO:0010922) | 3.01077663 |
| 153 | regulation of glucocorticoid metabolic process (GO:0031943) | 3.00468577 |
| 154 | peroxisome fission (GO:0016559) | 3.00329514 |
| 155 | negative regulation of cardiac muscle hypertrophy (GO:0010614) | 2.99326189 |
| 156 | regulation of uterine smooth muscle contraction (GO:0070472) | 2.98250340 |
| 157 | muscle tissue development (GO:0060537) | 2.96887594 |
| 158 | lung epithelium development (GO:0060428) | 2.96804011 |
| 159 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.96511053 |
| 160 | regulation of potassium ion transmembrane transport (GO:1901379) | 2.95855878 |
| 161 | muscle cell development (GO:0055001) | 2.93722108 |
| 162 | protein localization to cell surface (GO:0034394) | 2.91901982 |
| 163 | regulation of histone H3-K27 methylation (GO:0061085) | 2.89051937 |
| 164 | growth hormone receptor signaling pathway (GO:0060396) | 2.88479946 |
| 165 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.88417233 |
| 166 | oocyte maturation (GO:0001556) | 2.88045286 |
| 167 | positive regulation of protein homodimerization activity (GO:0090073) | 2.87455077 |
| 168 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.87116062 |
| 169 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.87116062 |
| 170 | fibril organization (GO:0097435) | 2.86813064 |
| 171 | adult feeding behavior (GO:0008343) | 2.83985374 |
| 172 | regulation of retinoic acid receptor signaling pathway (GO:0048385) | 2.83003320 |
| 173 | mitotic chromosome condensation (GO:0007076) | 2.82879763 |
| 174 | regulation of mononuclear cell migration (GO:0071675) | 2.82309146 |
| 175 | tongue development (GO:0043586) | 2.80368862 |
| 176 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.77340103 |
| 177 | regulation of macrophage chemotaxis (GO:0010758) | 2.77158384 |
| 178 | metaphase plate congression (GO:0051310) | 2.76691906 |
| 179 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.76593092 |
| 180 | fatty acid transmembrane transport (GO:1902001) | 2.75958168 |
| 181 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.74828898 |
| 182 | female gonad development (GO:0008585) | 2.73610765 |
| 183 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.73503824 |
| 184 | axonemal dynein complex assembly (GO:0070286) | 2.72187655 |
| 185 | response to dietary excess (GO:0002021) | 2.72042774 |
| 186 | potassium ion export (GO:0071435) | 2.71860019 |
| 187 | cell junction maintenance (GO:0034331) | 2.70998309 |
| 188 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.63080725 |
| 189 | regulation of fatty acid oxidation (GO:0046320) | 2.62605311 |
| 190 | folic acid transport (GO:0015884) | 2.62544811 |
| 191 | regulation of spindle organization (GO:0090224) | 2.62373091 |
| 192 | glycerol metabolic process (GO:0006071) | 2.62263292 |
| 193 | female genitalia development (GO:0030540) | 2.58988473 |
| 194 | synaptonemal complex assembly (GO:0007130) | 2.58896781 |
| 195 | negative regulation of smooth muscle cell differentiation (GO:0051151) | 2.58808203 |
| 196 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.58645154 |
| 197 | skeletal muscle contraction (GO:0003009) | 13.4638029 |
| 198 | actin-myosin filament sliding (GO:0033275) | 13.0330433 |
| 199 | muscle filament sliding (GO:0030049) | 13.0330433 |
| 200 | actin-mediated cell contraction (GO:0070252) | 10.8216323 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.79123582 |
| 2 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 6.16930265 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.15416950 |
| 4 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.94263059 |
| 5 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 3.47974185 |
| 6 | IGF1R_20145208_ChIP-Seq_DFB_Human | 3.13942081 |
| 7 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 3.13269546 |
| 8 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.03995564 |
| 9 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 2.45106954 |
| 10 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.32572879 |
| 11 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.30276119 |
| 12 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.22257549 |
| 13 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.18919691 |
| 14 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 2.18243281 |
| 15 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 2.13469548 |
| 16 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.09186384 |
| 17 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.05320228 |
| 18 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.99950138 |
| 19 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.94161205 |
| 20 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.85291672 |
| 21 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.85240327 |
| 22 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.78887469 |
| 23 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.78887469 |
| 24 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.78831030 |
| 25 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.78361391 |
| 26 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.78087527 |
| 27 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.77332061 |
| 28 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.77235752 |
| 29 | FUS_26573619_Chip-Seq_HEK293_Human | 1.73067043 |
| 30 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.72884622 |
| 31 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.64212747 |
| 32 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.63283343 |
| 33 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.61853459 |
| 34 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.60549588 |
| 35 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.59848905 |
| 36 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.58830697 |
| 37 | CJUN_26792858_Chip-Seq_BT549_Human | 1.58469148 |
| 38 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.57465306 |
| 39 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.56193895 |
| 40 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.55307577 |
| 41 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.55287505 |
| 42 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.55285044 |
| 43 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.54504839 |
| 44 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.53493159 |
| 45 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.53372184 |
| 46 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.52977227 |
| 47 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.50536258 |
| 48 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.47879376 |
| 49 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.45958934 |
| 50 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.44549933 |
| 51 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.44309423 |
| 52 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.42210705 |
| 53 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.41473312 |
| 54 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.40634361 |
| 55 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.37591351 |
| 56 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.37100565 |
| 57 | STAT3_23295773_ChIP-Seq_U87_Human | 1.35473985 |
| 58 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.33877936 |
| 59 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.32443864 |
| 60 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.32077170 |
| 61 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.31121481 |
| 62 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.30402945 |
| 63 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.30301090 |
| 64 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.28865705 |
| 65 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.27944082 |
| 66 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.27793393 |
| 67 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.27601746 |
| 68 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.26899045 |
| 69 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.26844213 |
| 70 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.25034121 |
| 71 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.24927294 |
| 72 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22409287 |
| 73 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.22159627 |
| 74 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.20754279 |
| 75 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.20668201 |
| 76 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.19659251 |
| 77 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.19351817 |
| 78 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.15976333 |
| 79 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.14934251 |
| 80 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.13274007 |
| 81 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.13135217 |
| 82 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.11886494 |
| 83 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.10974923 |
| 84 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.10532226 |
| 85 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.09077159 |
| 86 | TP53_16413492_ChIP-PET_HCT116_Human | 1.07941071 |
| 87 | AR_25329375_ChIP-Seq_VCAP_Human | 1.07800066 |
| 88 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.07604755 |
| 89 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.07162255 |
| 90 | KDM2B_26808549_Chip-Seq_REH_Human | 1.06892528 |
| 91 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.06216160 |
| 92 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.06008576 |
| 93 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.05186521 |
| 94 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.05125537 |
| 95 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.05104846 |
| 96 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.04695711 |
| 97 | RXR_22108803_ChIP-Seq_LS180_Human | 1.03973270 |
| 98 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.03631032 |
| 99 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.03626671 |
| 100 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.02261435 |
| 101 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.02205617 |
| 102 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.01189616 |
| 103 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.01097825 |
| 104 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.00669973 |
| 105 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.99703230 |
| 106 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.99668877 |
| 107 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.99566958 |
| 108 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.99411394 |
| 109 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.98845429 |
| 110 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.98746448 |
| 111 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.97300894 |
| 112 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.96742945 |
| 113 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.96537495 |
| 114 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.95604476 |
| 115 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.95455124 |
| 116 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.95414114 |
| 117 | TBL1_22424771_ChIP-Seq_293T_Human | 0.95202232 |
| 118 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.94824761 |
| 119 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.94422378 |
| 120 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.93704139 |
| 121 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.93252500 |
| 122 | VDR_22108803_ChIP-Seq_LS180_Human | 0.92509098 |
| 123 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.91741680 |
| 124 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.90924777 |
| 125 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.90845044 |
| 126 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.90350308 |
| 127 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.90264654 |
| 128 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.90096503 |
| 129 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.90095585 |
| 130 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.89886310 |
| 131 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.89779755 |
| 132 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.89420870 |
| 133 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.89137511 |
| 134 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.88972308 |
| 135 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.88269245 |
| 136 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.87620929 |
| 137 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.87412829 |
| 138 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.87358264 |
| 139 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.87317422 |
| 140 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.87293455 |
| 141 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.86749803 |
| 142 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.86343812 |
| 143 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.86015120 |
| 144 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.85329744 |
| 145 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.85329744 |
| 146 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.84876253 |
| 147 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84543585 |
| 148 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.84543585 |
| 149 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.84254458 |
| 150 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.83804884 |
| 151 | CEBPB_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.83517914 |
| 152 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.83350894 |
| 153 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.83196234 |
| 154 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.83195642 |
| 155 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82936169 |
| 156 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.82931220 |
| 157 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.82429977 |
| 158 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.82377061 |
| 159 | TCF4_23295773_ChIP-Seq_U87_Human | 0.82284946 |
| 160 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.81906000 |
| 161 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.81883971 |
| 162 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.81502464 |
| 163 | AR_19668381_ChIP-Seq_PC3_Human | 0.81262136 |
| 164 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.81088514 |
| 165 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.80474131 |
| 166 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.79976305 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003011_delayed_dark_adaptation | 6.49970238 |
| 2 | MP0005666_abnormal_adipose_tissue | 5.26053826 |
| 3 | MP0005670_abnormal_white_adipose | 4.83392586 |
| 4 | MP0003646_muscle_fatigue | 4.13964663 |
| 5 | MP0004185_abnormal_adipocyte_glucose | 3.50370946 |
| 6 | MP0005375_adipose_tissue_phenotype | 3.38123571 |
| 7 | MP0005451_abnormal_body_composition | 3.34314521 |
| 8 | MP0003122_maternal_imprinting | 3.18254906 |
| 9 | MP0002971_abnormal_brown_adipose | 3.09587608 |
| 10 | MP0000013_abnormal_adipose_tissue | 2.92362337 |
| 11 | MP0001958_emphysema | 2.90239017 |
| 12 | MP0004036_abnormal_muscle_relaxation | 2.90232105 |
| 13 | MP0004084_abnormal_cardiac_muscle | 2.84440866 |
| 14 | MP0000747_muscle_weakness | 2.83001154 |
| 15 | MP0008438_abnormal_cutaneous_collagen | 2.73355506 |
| 16 | MP0008004_abnormal_stomach_pH | 2.70606749 |
| 17 | MP0002269_muscular_atrophy | 2.62660909 |
| 18 | MP0004130_abnormal_muscle_cell | 2.48328231 |
| 19 | MP0002653_abnormal_ependyma_morphology | 2.45414850 |
| 20 | MP0005503_abnormal_tendon_morphology | 2.42475294 |
| 21 | MP0002837_dystrophic_cardiac_calcinosis | 2.34599921 |
| 22 | MP0003718_maternal_effect | 2.30360756 |
| 23 | MP0009115_abnormal_fat_cell | 2.12107256 |
| 24 | MP0005395_other_phenotype | 2.09503230 |
| 25 | MP0000003_abnormal_adipose_tissue | 2.07607587 |
| 26 | MP0003186_abnormal_redox_activity | 2.04748908 |
| 27 | MP0002876_abnormal_thyroid_physiology | 2.02552339 |
| 28 | MP0002102_abnormal_ear_morphology | 2.01021504 |
| 29 | MP0002168_other_aberrant_phenotype | 1.97712474 |
| 30 | MP0005646_abnormal_pituitary_gland | 1.90224526 |
| 31 | MP0002970_abnormal_white_adipose | 1.87121239 |
| 32 | MP0009384_cardiac_valve_regurgitation | 1.79507233 |
| 33 | MP0002163_abnormal_gland_morphology | 1.77359064 |
| 34 | MP0003705_abnormal_hypodermis_morpholog | 1.65212500 |
| 35 | MP0004019_abnormal_vitamin_homeostasis | 1.63838685 |
| 36 | MP0005275_abnormal_skin_tensile | 1.51984103 |
| 37 | MP0006276_abnormal_autonomic_nervous | 1.46335332 |
| 38 | MP0005535_abnormal_body_temperature | 1.41424395 |
| 39 | MP0002249_abnormal_larynx_morphology | 1.38853678 |
| 40 | MP0001542_abnormal_bone_strength | 1.35542843 |
| 41 | MP0003950_abnormal_plasma_membrane | 1.34914066 |
| 42 | MP0003121_genomic_imprinting | 1.30665446 |
| 43 | MP0002332_abnormal_exercise_endurance | 1.26908362 |
| 44 | MP0005408_hypopigmentation | 1.25530839 |
| 45 | MP0005334_abnormal_fat_pad | 1.24477679 |
| 46 | MP0003699_abnormal_female_reproductive | 1.22415580 |
| 47 | MP0010329_abnormal_lipoprotein_level | 1.20255008 |
| 48 | MP0001929_abnormal_gametogenesis | 1.19470346 |
| 49 | MP0004272_abnormal_basement_membrane | 1.19146608 |
| 50 | MP0001119_abnormal_female_reproductive | 1.19123929 |
| 51 | MP0009780_abnormal_chondrocyte_physiolo | 1.15741255 |
| 52 | MP0010368_abnormal_lymphatic_system | 1.13406665 |
| 53 | MP0002108_abnormal_muscle_morphology | 1.11137214 |
| 54 | MP0005620_abnormal_muscle_contractility | 1.09245418 |
| 55 | MP0003123_paternal_imprinting | 1.07787469 |
| 56 | MP0006138_congestive_heart_failure | 1.05586772 |
| 57 | MP0001915_intracranial_hemorrhage | 1.05444750 |
| 58 | MP0004087_abnormal_muscle_fiber | 1.02931273 |
| 59 | MP0010030_abnormal_orbit_morphology | 1.01879397 |
| 60 | MP0005379_endocrine/exocrine_gland_phen | 1.01361665 |
| 61 | MP0000534_abnormal_ureter_morphology | 1.00712580 |
| 62 | MP0000653_abnormal_sex_gland | 0.99937160 |
| 63 | MP0003329_amyloid_beta_deposits | 0.99426431 |
| 64 | MP0004134_abnormal_chest_morphology | 0.97730978 |
| 65 | MP0005595_abnormal_vascular_smooth | 0.91803327 |
| 66 | MP0000751_myopathy | 0.91371532 |
| 67 | MP0003879_abnormal_hair_cell | 0.90169904 |
| 68 | MP0008877_abnormal_DNA_methylation | 0.89071104 |
| 69 | MP0001346_abnormal_lacrimal_gland | 0.87428847 |
| 70 | MP0000767_abnormal_smooth_muscle | 0.87175087 |
| 71 | MP0004484_altered_response_of | 0.85499107 |
| 72 | MP0005330_cardiomyopathy | 0.84348012 |
| 73 | MP0003045_fibrosis | 0.84139936 |
| 74 | MP0005623_abnormal_meninges_morphology | 0.82473013 |
| 75 | MP0004215_abnormal_myocardial_fiber | 0.81652881 |
| 76 | MP0005452_abnormal_adipose_tissue | 0.78658758 |
| 77 | MP0002060_abnormal_skin_morphology | 0.78229499 |
| 78 | MP0000750_abnormal_muscle_regeneration | 0.78118904 |
| 79 | MP0002078_abnormal_glucose_homeostasis | 0.77421947 |
| 80 | MP0002118_abnormal_lipid_homeostasis | 0.77297182 |
| 81 | MP0001944_abnormal_pancreas_morphology | 0.77117115 |
| 82 | MP0000733_abnormal_muscle_development | 0.76255334 |
| 83 | MP0004145_abnormal_muscle_electrophysio | 0.75390870 |
| 84 | MP0003690_abnormal_glial_cell | 0.75223266 |
| 85 | MP0002295_abnormal_pulmonary_circulatio | 0.74790819 |
| 86 | MP0005647_abnormal_sex_gland | 0.74589442 |
| 87 | MP0004510_myositis | 0.74112398 |
| 88 | MP0001943_abnormal_respiration | 0.73513579 |
| 89 | MP0001544_abnormal_cardiovascular_syste | 0.73349478 |
| 90 | MP0005385_cardiovascular_system_phenoty | 0.73349478 |
| 91 | MP0005266_abnormal_metabolism | 0.73166149 |
| 92 | MP0002638_abnormal_pupillary_reflex | 0.72270141 |
| 93 | MP0002210_abnormal_sex_determination | 0.72040682 |
| 94 | MP0002972_abnormal_cardiac_muscle | 0.71661485 |
| 95 | MP0003937_abnormal_limbs/digits/tail_de | 0.71108024 |
| 96 | MP0005508_abnormal_skeleton_morphology | 0.70738670 |
| 97 | MP0002734_abnormal_mechanical_nocicepti | 0.70720045 |
| 98 | MP0002114_abnormal_axial_skeleton | 0.69580929 |
| 99 | MP0003136_yellow_coat_color | 0.68649755 |
| 100 | MP0002161_abnormal_fertility/fecundity | 0.68586317 |
| 101 | MP0003942_abnormal_urinary_system | 0.67665819 |
| 102 | MP0001881_abnormal_mammary_gland | 0.67162224 |
| 103 | MP0001145_abnormal_male_reproductive | 0.66541521 |
| 104 | MP0005369_muscle_phenotype | 0.66159007 |
| 105 | MP0000749_muscle_degeneration | 0.65810980 |
| 106 | MP0000639_abnormal_adrenal_gland | 0.63509542 |
| 107 | MP0001501_abnormal_sleep_pattern | 0.63374131 |
| 108 | MP0003191_abnormal_cellular_cholesterol | 0.62821924 |
| 109 | MP0002822_catalepsy | 0.62722969 |
| 110 | MP0000631_abnormal_neuroendocrine_gland | 0.62543076 |
| 111 | MP0000372_irregular_coat_pigmentation | 0.62491434 |
| 112 | MP0003693_abnormal_embryo_hatching | 0.61664798 |
| 113 | MP0004270_analgesia | 0.60942639 |
| 114 | MP0003385_abnormal_body_wall | 0.60701254 |
| 115 | MP0003279_aneurysm | 0.59944915 |
| 116 | MP0000343_altered_response_to | 0.59701896 |
| 117 | MP0001851_eye_inflammation | 0.59597280 |
| 118 | MP0009250_abnormal_appendicular_skeleto | 0.59174096 |
| 119 | MP0001849_ear_inflammation | 0.59009027 |
| 120 | MP0004085_abnormal_heartbeat | 0.58818576 |
| 121 | MP0002233_abnormal_nose_morphology | 0.58359182 |
| 122 | MP0005410_abnormal_fertilization | 0.58033962 |
| 123 | MP0003787_abnormal_imprinting | 0.57441698 |
| 124 | MP0000266_abnormal_heart_morphology | 0.55476527 |
| 125 | MP0010630_abnormal_cardiac_muscle | 0.55433347 |
| 126 | MP0003091_abnormal_cell_migration | 0.53654535 |
| 127 | MP0000759_abnormal_skeletal_muscle | 0.53599413 |
| 128 | MP0001661_extended_life_span | 0.53479095 |
| 129 | MP0003137_abnormal_impulse_conducting | 0.52425636 |
| 130 | MP0002896_abnormal_bone_mineralization | 0.51212945 |
| 131 | MP0004233_abnormal_muscle_weight | 0.50875464 |
| 132 | MP0003948_abnormal_gas_homeostasis | 0.50830059 |
| 133 | MP0001984_abnormal_olfaction | 0.50464847 |
| 134 | MP0001299_abnormal_eye_distance/ | 0.50442123 |
| 135 | MP0000762_abnormal_tongue_morphology | 0.50275853 |
| 136 | MP0002106_abnormal_muscle_physiology | 0.50270789 |
| 137 | MP0000609_abnormal_liver_physiology | 0.50013061 |
| 138 | MP0000427_abnormal_hair_cycle | 0.49699741 |
| 139 | MP0002127_abnormal_cardiovascular_syste | 0.49262895 |
| 140 | MP0008789_abnormal_olfactory_epithelium | 0.47334492 |
| 141 | MP0002234_abnormal_pharynx_morphology | 0.46808470 |
| 142 | MP0000049_abnormal_middle_ear | 0.42818879 |
| 143 | MP0002109_abnormal_limb_morphology | 0.42139296 |
| 144 | MP0000462_abnormal_digestive_system | 0.41943645 |
| 145 | MP0002116_abnormal_craniofacial_bone | 0.40923234 |
| 146 | MP0002115_abnormal_skeleton_extremities | 0.37564446 |
| 147 | MP0002113_abnormal_skeleton_development | 0.36575274 |
| 148 | MP0003935_abnormal_craniofacial_develop | 0.34533847 |
| 149 | MP0005165_increased_susceptibility_to | 0.33147857 |
| 150 | MP0002128_abnormal_blood_circulation | 0.33116197 |
| 151 | MP0000230_abnormal_systemic_arterial | 0.31479926 |
| 152 | MP0000163_abnormal_cartilage_morphology | 0.31025193 |
| 153 | MP0008770_decreased_survivor_rate | 0.29916744 |
| 154 | MP0000432_abnormal_head_morphology | 0.29880179 |
| 155 | MP0003755_abnormal_palate_morphology | 0.29351848 |
| 156 | MP0005220_abnormal_exocrine_pancreas | 0.29262063 |
| 157 | MP0001614_abnormal_blood_vessel | 0.28121027 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ulnar deviation of the wrist (HP:0003049) | 9.83121787 |
| 2 | Male infertility (HP:0003251) | 7.17857414 |
| 3 | Absent phalangeal crease (HP:0006109) | 6.79761734 |
| 4 | Trismus (HP:0000211) | 6.57315979 |
| 5 | Breech presentation (HP:0001623) | 6.39745523 |
| 6 | Malignant hyperthermia (HP:0002047) | 5.96103168 |
| 7 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 5.95325446 |
| 8 | Abnormal finger flexion creases (HP:0006143) | 5.72047237 |
| 9 | Popliteal pterygium (HP:0009756) | 5.68710645 |
| 10 | Abnormality of the calcaneus (HP:0008364) | 5.52728038 |
| 11 | Insulin-resistant diabetes mellitus (HP:0000831) | 5.43796580 |
| 12 | Hypoalphalipoproteinemia (HP:0003233) | 5.13898122 |
| 13 | Acanthosis nigricans (HP:0000956) | 4.63555737 |
| 14 | Distal arthrogryposis (HP:0005684) | 4.45419331 |
| 15 | Chin dimple (HP:0010751) | 4.42123272 |
| 16 | Aplasia of the musculature (HP:0100854) | 4.40997431 |
| 17 | Neoplasm of the heart (HP:0100544) | 4.36079639 |
| 18 | Vascular tortuosity (HP:0004948) | 4.12976623 |
| 19 | Amniotic constriction ring (HP:0009775) | 4.04278738 |
| 20 | Abnormality of placental membranes (HP:0011409) | 4.04278738 |
| 21 | Subcapsular cataract (HP:0000523) | 3.99808701 |
| 22 | Hyperphosphatemia (HP:0002905) | 3.97426568 |
| 23 | Oligomenorrhea (HP:0000876) | 3.91871618 |
| 24 | Tubulointerstitial nephritis (HP:0001970) | 3.75921600 |
| 25 | Vascular calcification (HP:0004934) | 3.73907630 |
| 26 | Abnormal auditory evoked potentials (HP:0006958) | 3.71185810 |
| 27 | Cardiovascular calcification (HP:0011915) | 3.68959620 |
| 28 | Chronic bronchitis (HP:0004469) | 3.66621775 |
| 29 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 3.61723039 |
| 30 | Arterial tortuosity (HP:0005116) | 3.60181116 |
| 31 | Hypertriglyceridemia (HP:0002155) | 3.54108152 |
| 32 | Ankle contracture (HP:0006466) | 3.51424186 |
| 33 | Exercise-induced myalgia (HP:0003738) | 3.50773126 |
| 34 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.50757971 |
| 35 | Akinesia (HP:0002304) | 3.45869091 |
| 36 | Abnormality of renal resorption (HP:0011038) | 3.45854034 |
| 37 | Taurodontia (HP:0000679) | 3.44891901 |
| 38 | Abnormality of permanent molar morphology (HP:0011071) | 3.44891901 |
| 39 | Abnormality of the dental root (HP:0006486) | 3.44891901 |
| 40 | Abnormality of molar (HP:0011077) | 3.28501022 |
| 41 | Abnormality of molar morphology (HP:0011070) | 3.28501022 |
| 42 | Calf muscle hypertrophy (HP:0008981) | 3.26697494 |
| 43 | Adrenal hypoplasia (HP:0000835) | 3.24938290 |
| 44 | Papillary thyroid carcinoma (HP:0002895) | 3.10791445 |
| 45 | Myopathic facies (HP:0002058) | 3.02211427 |
| 46 | Menstrual irregularities (HP:0000858) | 3.00232539 |
| 47 | Abnormality of the dental pulp (HP:0006479) | 3.00198103 |
| 48 | Limited hip movement (HP:0008800) | 2.99149707 |
| 49 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.87953319 |
| 50 | Abnormality of the calf musculature (HP:0001430) | 2.86115464 |
| 51 | Ulnar deviation of finger (HP:0009465) | 2.81642811 |
| 52 | Type 1 muscle fiber predominance (HP:0003803) | 2.81298400 |
| 53 | Cone-rod dystrophy (HP:0000548) | 2.81061837 |
| 54 | Hyporeflexia of lower limbs (HP:0002600) | 2.79669527 |
| 55 | Infertility (HP:0000789) | 2.77191407 |
| 56 | Rhinitis (HP:0012384) | 2.75276540 |
| 57 | Chronic hepatic failure (HP:0100626) | 2.72834693 |
| 58 | Tarsal synostosis (HP:0008368) | 2.71537293 |
| 59 | Aortic aneurysm (HP:0004942) | 2.70157956 |
| 60 | Insulin resistance (HP:0000855) | 2.69423365 |
| 61 | Type 2 muscle fiber atrophy (HP:0003554) | 2.69421588 |
| 62 | Gowers sign (HP:0003391) | 2.69106480 |
| 63 | Thin ribs (HP:0000883) | 2.61642164 |
| 64 | Increased purine levels (HP:0004368) | 2.60750801 |
| 65 | Hyperuricemia (HP:0002149) | 2.60750801 |
| 66 | Abnormality of the aortic arch (HP:0012303) | 2.58743149 |
| 67 | Increased connective tissue (HP:0009025) | 2.57776264 |
| 68 | Spondylolisthesis (HP:0003302) | 2.57464799 |
| 69 | Abnormal delivery (HP:0001787) | 2.54114095 |
| 70 | Adducted thumb (HP:0001181) | 2.53644216 |
| 71 | Renovascular hypertension (HP:0100817) | 2.53303562 |
| 72 | Synostosis involving bones of the lower limbs (HP:0009138) | 2.50874030 |
| 73 | Synostosis involving bones of the feet (HP:0009140) | 2.50874030 |
| 74 | EMG: myopathic abnormalities (HP:0003458) | 2.50131020 |
| 75 | Long clavicles (HP:0000890) | 2.49469355 |
| 76 | Webbed neck (HP:0000465) | 2.49314870 |
| 77 | Abnormality of the neuromuscular junction (HP:0003398) | 2.46894012 |
| 78 | Fatigable weakness (HP:0003473) | 2.46894012 |
| 79 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.45479255 |
| 80 | Rocker bottom foot (HP:0001838) | 2.44321259 |
| 81 | Sudden death (HP:0001699) | 2.40651245 |
| 82 | Aortic dissection (HP:0002647) | 2.40071470 |
| 83 | Hyperglycinuria (HP:0003108) | 2.38655800 |
| 84 | Abnormal ciliary motility (HP:0012262) | 2.37162308 |
| 85 | Pterygium (HP:0001059) | 2.35936543 |
| 86 | Muscle fiber atrophy (HP:0100295) | 2.35333490 |
| 87 | Exercise-induced muscle cramps (HP:0003710) | 2.33479906 |
| 88 | Hypolipoproteinemia (HP:0010981) | 2.33357460 |
| 89 | Neck muscle weakness (HP:0000467) | 2.31785587 |
| 90 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 2.30917126 |
| 91 | Hypergonadotropic hypogonadism (HP:0000815) | 2.29212132 |
| 92 | Cortical dysplasia (HP:0002539) | 2.27984272 |
| 93 | Thyroid carcinoma (HP:0002890) | 2.26790006 |
| 94 | Pulmonary fibrosis (HP:0002206) | 2.26727578 |
| 95 | Absent/shortened dynein arms (HP:0200106) | 2.25108298 |
| 96 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.25108298 |
| 97 | Truncal obesity (HP:0001956) | 2.23599496 |
| 98 | Mask-like facies (HP:0000298) | 2.23340199 |
| 99 | Hypoplasia of the uterus (HP:0000013) | 2.22770159 |
| 100 | Capillary hemangiomas (HP:0005306) | 2.22137002 |
| 101 | Generalized aminoaciduria (HP:0002909) | 2.19237592 |
| 102 | Increased variability in muscle fiber diameter (HP:0003557) | 2.18931556 |
| 103 | Orthostatic hypotension (HP:0001278) | 2.18608324 |
| 104 | Calcaneovalgus deformity (HP:0001848) | 2.18001515 |
| 105 | Knee flexion contracture (HP:0006380) | 2.17461242 |
| 106 | Genu recurvatum (HP:0002816) | 2.15367266 |
| 107 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.14985860 |
| 108 | Aplasia involving bones of the extremities (HP:0009825) | 2.14777835 |
| 109 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.14777835 |
| 110 | Aplasia of the phalanges of the hand (HP:0009802) | 2.14777835 |
| 111 | Shawl scrotum (HP:0000049) | 2.14761403 |
| 112 | Nasal speech (HP:0001611) | 2.14746703 |
| 113 | Fetal akinesia sequence (HP:0001989) | 2.14368372 |
| 114 | Asymmetric septal hypertrophy (HP:0001670) | 2.13697007 |
| 115 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.13435895 |
| 116 | Nonprogressive disorder (HP:0003680) | 2.12244723 |
| 117 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.09595894 |
| 118 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.09028369 |
| 119 | Muscle fiber splitting (HP:0003555) | 2.08624931 |
| 120 | Cerebral aneurysm (HP:0004944) | 2.07957768 |
| 121 | Nemaline bodies (HP:0003798) | 2.04462688 |
| 122 | Flexion contracture of toe (HP:0005830) | 2.03729890 |
| 123 | Joint contractures involving the joints of the feet (HP:0100492) | 2.03729890 |
| 124 | Hypoplastic heart (HP:0001961) | 2.03195870 |
| 125 | Cystic hygroma (HP:0000476) | 1.98589147 |
| 126 | Deformed tarsal bones (HP:0008119) | 1.97940040 |
| 127 | Secondary amenorrhea (HP:0000869) | 1.97854271 |
| 128 | Shallow orbits (HP:0000586) | 1.97553210 |
| 129 | Myotonia (HP:0002486) | 1.96971825 |
| 130 | Abnormality of the fovea (HP:0000493) | 1.95388601 |
| 131 | Ventricular fibrillation (HP:0001663) | 1.95073637 |
| 132 | Weak cry (HP:0001612) | 1.93830160 |
| 133 | Neonatal respiratory distress (HP:0002643) | 1.93017528 |
| 134 | Difficulty running (HP:0009046) | 1.92436638 |
| 135 | Polar cataract (HP:0010696) | 1.91848992 |
| 136 | Camptodactyly of toe (HP:0001836) | 1.91806125 |
| 137 | Ketoacidosis (HP:0001993) | 1.87968058 |
| 138 | Enlarged penis (HP:0000040) | 1.86840683 |
| 139 | Fragile skin (HP:0001030) | 1.86056107 |
| 140 | Muscle fiber inclusion bodies (HP:0100299) | 1.85680807 |
| 141 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.83071284 |
| 142 | Protrusio acetabuli (HP:0003179) | 1.82326742 |
| 143 | Hip contracture (HP:0003273) | 1.81901691 |
| 144 | Goiter (HP:0000853) | 1.81842420 |
| 145 | Hypoplasia of dental enamel (HP:0006297) | 1.81679652 |
| 146 | Tubulointerstitial abnormality (HP:0001969) | 1.81678159 |
| 147 | Round ear (HP:0100830) | 1.81662531 |
| 148 | Subaortic stenosis (HP:0001682) | 1.81136629 |
| 149 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.81136629 |
| 150 | Nephritis (HP:0000123) | 1.81025866 |
| 151 | Striae distensae (HP:0001065) | 1.78452499 |
| 152 | Peritonitis (HP:0002586) | 1.77810153 |
| 153 | Bulbar palsy (HP:0001283) | 1.77184608 |
| 154 | Accelerated skeletal maturation (HP:0005616) | 1.76894698 |
| 155 | Abnormality of the hepatic vasculature (HP:0006707) | 1.73763794 |
| 156 | Hemiparesis (HP:0001269) | 1.72277402 |
| 157 | Abnormality of dentin (HP:0010299) | 1.71516987 |
| 158 | Cutaneous syndactyly (HP:0012725) | 1.71504224 |
| 159 | Metatarsus adductus (HP:0001840) | 1.70915930 |
| 160 | Progressive sensorineural hearing impairment (HP:0000408) | 1.70007257 |
| 161 | Annular pancreas (HP:0001734) | 1.69634851 |
| 162 | Chorioretinal atrophy (HP:0000533) | 1.69293184 |
| 163 | Diminished movement (HP:0002374) | 1.65318103 |
| 164 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.62259794 |
| 165 | Scapular winging (HP:0003691) | 1.60438891 |
| 166 | Vertebral clefting (HP:0008428) | 1.59227497 |
| 167 | Generalized muscle weakness (HP:0003324) | 1.57898165 |
| 168 | Soft skin (HP:0000977) | 1.54976349 |
| 169 | Limb-girdle muscle atrophy (HP:0003797) | 1.50750789 |
| 170 | Narrow mouth (HP:0000160) | 1.49603476 |
| 171 | Premature rupture of membranes (HP:0001788) | 1.49295586 |
| 172 | Hypoplastic ischia (HP:0003175) | 1.47353916 |
| 173 | Deep philtrum (HP:0002002) | 1.45930523 |
| 174 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.44324344 |
| 175 | Easy fatigability (HP:0003388) | 1.44133103 |
| 176 | Abnormality of the ischium (HP:0003174) | 1.43227921 |
| 177 | Rib fusion (HP:0000902) | 1.40906414 |
| 178 | Flat face (HP:0012368) | 1.40082168 |
| 179 | Narrow face (HP:0000275) | 1.38680299 |
| 180 | EMG: neuropathic changes (HP:0003445) | 1.37792618 |
| 181 | Hypoplastic nipples (HP:0002557) | 1.35978240 |
| 182 | Thin bony cortex (HP:0002753) | 1.35583017 |
| 183 | Asymmetry of the thorax (HP:0001555) | 1.34765044 |
| 184 | Arthrogryposis multiplex congenita (HP:0002804) | 1.33590820 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DDR2 | 4.17348617 |
| 2 | LATS1 | 4.13511245 |
| 3 | LATS2 | 4.03994472 |
| 4 | MAP3K6 | 3.30714964 |
| 5 | KSR2 | 3.13398834 |
| 6 | MAP3K10 | 3.12127512 |
| 7 | MUSK | 3.04703904 |
| 8 | MOS | 2.80042660 |
| 9 | MELK | 2.76537728 |
| 10 | EEF2K | 2.63715576 |
| 11 | TRIB3 | 2.63099301 |
| 12 | ERBB4 | 2.60410065 |
| 13 | PRKD3 | 2.59699165 |
| 14 | MAP3K9 | 2.40148160 |
| 15 | STK38L | 2.36388553 |
| 16 | TTK | 2.32151463 |
| 17 | NEK9 | 2.14139606 |
| 18 | PLK4 | 1.92952541 |
| 19 | TNIK | 1.89345079 |
| 20 | TAOK3 | 1.88586011 |
| 21 | RET | 1.81422617 |
| 22 | TTN | 1.80209741 |
| 23 | RAF1 | 1.79853228 |
| 24 | SCYL2 | 1.72170262 |
| 25 | MAPKAPK3 | 1.69132458 |
| 26 | PTK6 | 1.63479088 |
| 27 | TAOK1 | 1.62179600 |
| 28 | MAP3K13 | 1.58065093 |
| 29 | PAK6 | 1.55592222 |
| 30 | TIE1 | 1.50622904 |
| 31 | BRAF | 1.50298941 |
| 32 | MAP3K5 | 1.49737183 |
| 33 | MAP3K7 | 1.46730460 |
| 34 | STK3 | 1.46598154 |
| 35 | CAMK1D | 1.44988160 |
| 36 | FGFR4 | 1.43745115 |
| 37 | CDK9 | 1.42532819 |
| 38 | MAPK7 | 1.41802098 |
| 39 | ARAF | 1.37579470 |
| 40 | CHEK2 | 1.34713233 |
| 41 | CDK12 | 1.34383458 |
| 42 | CCNB1 | 1.29649079 |
| 43 | PRKAA2 | 1.29619443 |
| 44 | KSR1 | 1.24609543 |
| 45 | BMPR2 | 1.21326154 |
| 46 | ABL2 | 1.19790398 |
| 47 | MAPK15 | 1.14602240 |
| 48 | CDK19 | 1.12475403 |
| 49 | MARK1 | 1.06333463 |
| 50 | TESK1 | 1.04621218 |
| 51 | CDC7 | 1.03655265 |
| 52 | MAPK13 | 1.02960416 |
| 53 | NME1 | 0.99423960 |
| 54 | STK10 | 0.99241211 |
| 55 | DYRK2 | 0.97763575 |
| 56 | STK39 | 0.96389594 |
| 57 | STK38 | 0.94849938 |
| 58 | MAPK11 | 0.91660576 |
| 59 | PRKAA1 | 0.90496898 |
| 60 | MAPKAPK5 | 0.89378995 |
| 61 | EPHB1 | 0.89055638 |
| 62 | PDPK1 | 0.83034013 |
| 63 | CAMK1G | 0.82408599 |
| 64 | TRPM7 | 0.82205401 |
| 65 | DMPK | 0.81073460 |
| 66 | ILK | 0.80899157 |
| 67 | PRKD2 | 0.80839354 |
| 68 | NUAK1 | 0.80760820 |
| 69 | TYRO3 | 0.79680064 |
| 70 | PDK3 | 0.78408876 |
| 71 | PDK4 | 0.78408876 |
| 72 | MYLK | 0.77100269 |
| 73 | PDK1 | 0.76469374 |
| 74 | CASK | 0.72901056 |
| 75 | MAP3K4 | 0.72162175 |
| 76 | BCKDK | 0.71230214 |
| 77 | PHKG1 | 0.67632696 |
| 78 | PHKG2 | 0.67632696 |
| 79 | MAP2K1 | 0.67207006 |
| 80 | CAMK2G | 0.67004092 |
| 81 | AKT2 | 0.64140152 |
| 82 | CDK8 | 0.62969469 |
| 83 | FRK | 0.62002285 |
| 84 | MAP2K7 | 0.59451420 |
| 85 | JAK2 | 0.56723606 |
| 86 | MAP3K8 | 0.54281758 |
| 87 | KDR | 0.52869399 |
| 88 | PLK1 | 0.52553066 |
| 89 | WNK4 | 0.50668680 |
| 90 | MARK2 | 0.48899750 |
| 91 | PRKCH | 0.48493648 |
| 92 | SIK1 | 0.47882693 |
| 93 | NEK2 | 0.47335338 |
| 94 | LIMK1 | 0.45738059 |
| 95 | PIK3CA | 0.45524691 |
| 96 | RIPK1 | 0.44988552 |
| 97 | LMTK2 | 0.43809742 |
| 98 | ABL1 | 0.43015150 |
| 99 | PTK2 | 0.42580404 |
| 100 | NTRK2 | 0.41957882 |
| 101 | MAPK4 | 0.41560033 |
| 102 | CSK | 0.41411272 |
| 103 | PDK2 | 0.40307416 |
| 104 | NTRK3 | 0.39879392 |
| 105 | OBSCN | 0.39695767 |
| 106 | PRPF4B | 0.39501897 |
| 107 | PLK3 | 0.39333870 |
| 108 | CDK6 | 0.38038470 |
| 109 | PKN2 | 0.37289954 |
| 110 | RPS6KA3 | 0.36447527 |
| 111 | PRKACA | 0.36189939 |
| 112 | MAP2K4 | 0.35694974 |
| 113 | IGF1R | 0.34487191 |
| 114 | RPS6KB1 | 0.34167979 |
| 115 | STK24 | 0.33947159 |
| 116 | PASK | 0.33487868 |
| 117 | VRK1 | 0.33303896 |
| 118 | PIK3CG | 0.32645409 |
| 119 | WNK1 | 0.32587001 |
| 120 | ICK | 0.32028461 |
| 121 | PTK2B | 0.30320619 |
| 122 | CDC42BPA | 0.30043393 |
| 123 | CSNK1G1 | 0.29961792 |
| 124 | RPS6KB2 | 0.29741690 |
| 125 | PRKCQ | 0.28623071 |
| 126 | TGFBR2 | 0.28013506 |
| 127 | CAMK2A | 0.27959045 |
| 128 | CDK11A | 0.27680949 |
| 129 | PDGFRA | 0.26736488 |
| 130 | TESK2 | 0.26561177 |
| 131 | CDK15 | 0.26478110 |
| 132 | RPS6KA2 | 0.26159526 |
| 133 | FGFR2 | 0.25073294 |
| 134 | MAPK12 | 0.25062420 |
| 135 | EPHB2 | 0.24823247 |
| 136 | CSNK1D | 0.23916171 |
| 137 | KIT | 0.23536920 |
| 138 | ROCK2 | 0.22464742 |
| 139 | PRKACB | 0.22351370 |
| 140 | ERN1 | 0.22215525 |
| 141 | LRRK2 | 0.21935271 |
| 142 | PRKG1 | 0.21923192 |
| 143 | ROCK1 | 0.21161179 |
| 144 | MTOR | 0.21139405 |
| 145 | CDK18 | 0.20114089 |
| 146 | ERBB3 | 0.19878920 |
| 147 | SGK2 | 0.19851451 |
| 148 | MAPKAPK2 | 0.19256357 |
| 149 | CSNK1G2 | 0.16444689 |
| 150 | CSNK1A1L | 0.15807670 |
| 151 | TNK2 | 0.15795265 |
| 152 | PAK2 | 0.14739869 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.74254564 |
| 2 | PPAR signaling pathway_Homo sapiens_hsa03320 | 3.06557263 |
| 3 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.80045193 |
| 4 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 2.68912205 |
| 5 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.68803166 |
| 6 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.54458637 |
| 7 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 2.39135087 |
| 8 | Phototransduction_Homo sapiens_hsa04744 | 2.24946621 |
| 9 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.23260085 |
| 10 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.13018732 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.11790523 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.02572021 |
| 13 | Renin secretion_Homo sapiens_hsa04924 | 2.00190264 |
| 14 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.97735875 |
| 15 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.94246774 |
| 16 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.92814714 |
| 17 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.84323930 |
| 18 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.77704414 |
| 19 | Cell cycle_Homo sapiens_hsa04110 | 1.77300504 |
| 20 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.74516572 |
| 21 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.72768680 |
| 22 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.69859072 |
| 23 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.63342484 |
| 24 | Circadian entrainment_Homo sapiens_hsa04713 | 1.62652312 |
| 25 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.55335953 |
| 26 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.53374145 |
| 27 | Circadian rhythm_Homo sapiens_hsa04710 | 1.50106220 |
| 28 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.46642609 |
| 29 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.46422509 |
| 30 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.43308825 |
| 31 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.36342591 |
| 32 | Glioma_Homo sapiens_hsa05214 | 1.34665995 |
| 33 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.31215798 |
| 34 | Long-term potentiation_Homo sapiens_hsa04720 | 1.30961854 |
| 35 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.29968586 |
| 36 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.29164018 |
| 37 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.26024902 |
| 38 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.24610307 |
| 39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.24361346 |
| 40 | Olfactory transduction_Homo sapiens_hsa04740 | 1.21287138 |
| 41 | Viral myocarditis_Homo sapiens_hsa05416 | 1.20931408 |
| 42 | Melanogenesis_Homo sapiens_hsa04916 | 1.20701754 |
| 43 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.20164918 |
| 44 | Insulin secretion_Homo sapiens_hsa04911 | 1.17868117 |
| 45 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.17451139 |
| 46 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.16940248 |
| 47 | RNA degradation_Homo sapiens_hsa03018 | 1.14415038 |
| 48 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.13632646 |
| 49 | Retinol metabolism_Homo sapiens_hsa00830 | 1.13124879 |
| 50 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.06015902 |
| 51 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.04122802 |
| 52 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.02257461 |
| 53 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.01710524 |
| 54 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.01097430 |
| 55 | Endometrial cancer_Homo sapiens_hsa05213 | 1.01023107 |
| 56 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.01017172 |
| 57 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.99515094 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.99308993 |
| 59 | Adherens junction_Homo sapiens_hsa04520 | 0.98805357 |
| 60 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.98068943 |
| 61 | Insulin resistance_Homo sapiens_hsa04931 | 0.96709032 |
| 62 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.95942878 |
| 63 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.94536549 |
| 64 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.92904974 |
| 65 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.92431211 |
| 66 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.91708420 |
| 67 | Focal adhesion_Homo sapiens_hsa04510 | 0.91443090 |
| 68 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.90647719 |
| 69 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.89764705 |
| 70 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.89449947 |
| 71 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.87190628 |
| 72 | Prion diseases_Homo sapiens_hsa05020 | 0.86572550 |
| 73 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.85543709 |
| 74 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.85372077 |
| 75 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.84382532 |
| 76 | Colorectal cancer_Homo sapiens_hsa05210 | 0.83373447 |
| 77 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.82899204 |
| 78 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.81461142 |
| 79 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.79124623 |
| 80 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.78299836 |
| 81 | Carbon metabolism_Homo sapiens_hsa01200 | 0.77836050 |
| 82 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.77224151 |
| 83 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.76563814 |
| 84 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.71659432 |
| 85 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.68516978 |
| 86 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.68382262 |
| 87 | Peroxisome_Homo sapiens_hsa04146 | 0.67892236 |
| 88 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.67557751 |
| 89 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.67402466 |
| 90 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.66758878 |
| 91 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.66308299 |
| 92 | Gap junction_Homo sapiens_hsa04540 | 0.65629350 |
| 93 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.65505213 |
| 94 | Prostate cancer_Homo sapiens_hsa05215 | 0.65462486 |
| 95 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.64889290 |
| 96 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.64315499 |
| 97 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.63942801 |
| 98 | Platelet activation_Homo sapiens_hsa04611 | 0.63039607 |
| 99 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.62559293 |
| 100 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.61818462 |
| 101 | Malaria_Homo sapiens_hsa05144 | 0.61396977 |
| 102 | Long-term depression_Homo sapiens_hsa04730 | 0.61381753 |
| 103 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.61112436 |
| 104 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.60954459 |
| 105 | Pertussis_Homo sapiens_hsa05133 | 0.59614313 |
| 106 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.58814093 |
| 107 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.58212381 |
| 108 | Basal transcription factors_Homo sapiens_hsa03022 | 0.57256032 |
| 109 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.57032888 |
| 110 | Bile secretion_Homo sapiens_hsa04976 | 0.56383510 |
| 111 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.56367312 |
| 112 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.56210088 |
| 113 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.56202292 |
| 114 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.56092600 |
| 115 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.54953513 |
| 116 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53238912 |
| 117 | Axon guidance_Homo sapiens_hsa04360 | 0.53077997 |
| 118 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.51719788 |
| 119 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.50464050 |
| 120 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.50220158 |
| 121 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.48947126 |
| 122 | Tight junction_Homo sapiens_hsa04530 | 0.47406243 |
| 123 | Thyroid cancer_Homo sapiens_hsa05216 | 0.44667571 |
| 124 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.42888016 |
| 125 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.42346738 |
| 126 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.41895527 |
| 127 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.41557410 |
| 128 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.40535431 |
| 129 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.40043572 |
| 130 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.39544528 |
| 131 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.39135021 |
| 132 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.37227449 |
| 133 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.36498449 |
| 134 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.36430002 |
| 135 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.36045248 |
| 136 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.35498853 |
| 137 | Salivary secretion_Homo sapiens_hsa04970 | 0.35403096 |
| 138 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.33618534 |
| 139 | Mineral absorption_Homo sapiens_hsa04978 | 0.33545095 |
| 140 | Melanoma_Homo sapiens_hsa05218 | 0.32047863 |
| 141 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.31880070 |
| 142 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.31827112 |
| 143 | Cocaine addiction_Homo sapiens_hsa05030 | 0.31155669 |
| 144 | Amoebiasis_Homo sapiens_hsa05146 | 0.29764341 |
| 145 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.29549309 |
| 146 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.28571362 |
| 147 | Pathways in cancer_Homo sapiens_hsa05200 | 0.27168326 |
| 148 | Lysine degradation_Homo sapiens_hsa00310 | 0.25031768 |
| 149 | Histidine metabolism_Homo sapiens_hsa00340 | 0.24884015 |
| 150 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.22155893 |
| 151 | Alcoholism_Homo sapiens_hsa05034 | 0.21037253 |
| 152 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.18942816 |

